Welcome
Support Centre
02 September 2010 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The introduction and evaluation of patient-clinician email communication in Merseyside clinical genetics service
Source of recordUK Trials
ISRCTNISRCTN18421278
Date ISRCTN assigned29/09/2006
Local reference number(s)N0128162659
Public titleThe introduction and evaluation of patient-clinician email communication in Merseyside clinical genetics service
Scientific title
AcronymN/A
Disease/condition/study domainNot Applicable:
Study hypothesisDoes email communication have a role in the patient-clinician relationship in clinical genetics? Would patients, who present to the clinical genetics team, use email to communicate with the department?
Design/methodologyRandomised controlled trial
Research ethics reviewNo ethics information provided as of 29 September 2006
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Referral to clinical genetics
2. Over 16 yrs of age or the parent/guardian of children under 16 yrs of age
3. With access to email
Participants - exclusion criteriaPatients attending for prenatal counselling or predictive testing.
Patient information material
Anticipated start date20/04/2005
Anticipated end date20/10/2006
Status of trialCompleted
Target number of participants120 participants in total (60 per arm)
InterventionsRandomised controlled trial. Intervention group: email address and telephone number. Control group: telephone number only.

Patients will be identified and invited to take part in the study at two separate points in the referral pathway:
1. At the home visit by a genetic counsellor.
2. At the clinic visit by a clinical geneticist and/or Dr Emma McCann.
Primary outcome measure(s)Comparison of "email and telephone" group with "telephone" group only. Is there a difference in the proportions contacting the department? Assess number of contacts per person.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingLiverpool Women's Hospital NHS Trust

NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2006 Update - Department of Health
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameDr Emma McCann
Contact detailsc/o Royal Liverpool Children's Hospital
Eaton Road


Liverpool
United Kingdom
L12 2AP
Contact telephone+44 0151 252 5239
Contact fax+44 0151 252 5951
Contact emailemma.mccann@rlc.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN18421278
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central